177 related articles for article (PubMed ID: 18309017)
21. Combination Tissue Plasminogen Activator and DNase for Loculated Malignant Pleural Effusions: A Single-center Retrospective Review.
Chan C; Sekowski V; Zheng B; Li P; Stollery D; Veenstra J; Gillson AM
J Bronchology Interv Pulmonol; 2023 Jul; 30(3):238-243. PubMed ID: 35698287
[TBL] [Abstract][Full Text] [Related]
22. The Use of Intrapleural Thrombolytic or Fibrinolytic Therapy, or Both, via Indwelling Tunneled Pleural Catheters With or Without Concurrent Anticoagulation Use.
Gilbert CR; Wilshire CL; Chang SC; Gorden JA
Chest; 2021 Aug; 160(2):776-783. PubMed ID: 33745991
[TBL] [Abstract][Full Text] [Related]
23. Management of complicated parapneumonic effusions in children.
Feola GP; Shaw LC; Coburn L
Tech Vasc Interv Radiol; 2003 Dec; 6(4):197-204. PubMed ID: 14767852
[TBL] [Abstract][Full Text] [Related]
24. Impact of fibrinolytics on the outcome of empyema in South African children.
Zampoli M; Kappos A; Verwey C; Mamathuba R; Zar HJ
S Afr Med J; 2015 Sep; 105(7):549-53. PubMed ID: 26428749
[TBL] [Abstract][Full Text] [Related]
25. Safety and Efficacy of Intrapleural Tissue Plasminogen Activator and DNase during Extended Use in Complicated Pleural Space Infections.
McClune JR; Wilshire CL; Gorden JA; Louie BE; Farviar AS; Stefanski MJ; Vallieres E; Aye RW; Gilbert CR
Can Respir J; 2016; 2016():9796768. PubMed ID: 27445574
[TBL] [Abstract][Full Text] [Related]
26. Tissue plasminogen activator as an adjuvant therapy for pleural empyema in pediatric patients.
Ray TL; Berkenbosch JW; Russo P; Tobias JD
J Intensive Care Med; 2004; 19(1):44-50. PubMed ID: 15035754
[TBL] [Abstract][Full Text] [Related]
27. Fibrinolytic treatment of complicated pediatric thoracic empyemas with intrapleural streptokinase.
Ekingen G; Güvenç BH; Sözübir S; Tuzlaci A; Senel U
Eur J Cardiothorac Surg; 2004 Sep; 26(3):503-7. PubMed ID: 15302043
[TBL] [Abstract][Full Text] [Related]
28. [Current value of intrapleural fibrinolysis in the treatment of exudative fibrinous pleural effusions in pleural empyema and hemothorax].
Kemper P; Köhler D
Pneumologie; 1999 Aug; 53(8):373-84. PubMed ID: 10483276
[TBL] [Abstract][Full Text] [Related]
29. A study of loculated tuberculous pleural effusions treated with intrapleural urokinase.
Cases Viedma E; Lorenzo Dus MJ; González-Molina A; Sanchis Aldás JL
Respir Med; 2006 Nov; 100(11):2037-42. PubMed ID: 16580190
[TBL] [Abstract][Full Text] [Related]
30. Intrapleural tissue plasminogen activator for complicated pleural effusions.
Skeete DA; Rutherford EJ; Schlidt SA; Abrams JE; Parker LA; Rich PB
J Trauma; 2004 Dec; 57(6):1178-83. PubMed ID: 15625447
[TBL] [Abstract][Full Text] [Related]
31. Management of Intrapleural Sepsis with Once Daily Use of Tissue Plasminogen Activator and Deoxyribonuclease.
Mehta HJ; Biswas A; Penley AM; Cope J; Barnes M; Jantz MA
Respiration; 2016; 91(2):101-6. PubMed ID: 26761711
[TBL] [Abstract][Full Text] [Related]
32. Intrapleural Fibrinolysis for the Treatment of Indwelling Pleural Catheter-Related Symptomatic Loculations: A Multicenter Observational Study.
Thomas R; Piccolo F; Miller D; MacEachern PR; Chee AC; Huseini T; Yarmus L; Bhatnagar R; Lee HJ; Feller-Kopman D; Maskell NA; Tremblay A; Lee YCG
Chest; 2015 Sep; 148(3):746-751. PubMed ID: 25742001
[TBL] [Abstract][Full Text] [Related]
33. Intraventricular tissue plasminogen activator for the prevention of vasospasm and hydrocephalus after aneurysmal subarachnoid hemorrhage.
Ramakrishna R; Sekhar LN; Ramanathan D; Temkin N; Hallam D; Ghodke BV; Kim LJ
Neurosurgery; 2010 Jul; 67(1):110-7; discussion 117. PubMed ID: 20559098
[TBL] [Abstract][Full Text] [Related]
34. Mixing It Up: Coadministration of tPA/DNase in Complicated Parapneumonic Pleural Effusions and Empyema.
Bishwakarma R; Shah S; Frank L; Zhang W; Sharma G; Nishi SP
J Bronchology Interv Pulmonol; 2017 Jan; 24(1):40-47. PubMed ID: 27984384
[TBL] [Abstract][Full Text] [Related]
35. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
[TBL] [Abstract][Full Text] [Related]
36. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.
Mathews MS; Sharma J; Snyder KV; Natarajan SK; Siddiqui AH; Hopkins LN; Levy EI
Neurosurgery; 2009 Nov; 65(5):860-5; discussion 865. PubMed ID: 19834397
[TBL] [Abstract][Full Text] [Related]
37. Post-licensed 1-year experience of systemic thrombolysis with tissue plasminogen activator for ischemic stroke in a Japanese neuro-unit.
Yoneda Y; Yamamoto S; Hara Y; Ohta K; Matsushita M; Yamamoto D; Yamashita H; Hosoda K
Clin Neurol Neurosurg; 2007 Sep; 109(7):567-70. PubMed ID: 17573188
[TBL] [Abstract][Full Text] [Related]
38. Intrapleural streptokinase for the treatment of childhood empyema.
Ho MY; Chen HY; Yen YH; Yang YS; Lien SH
Acta Paediatr Taiwan; 2007; 48(5):251-6. PubMed ID: 18254573
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of local instillation of recombinant tissue plasminogen activator for restoring occluded central venous catheters in neonates.
Soylu H; Brandão LR; Lee KS
J Pediatr; 2010 Feb; 156(2):197-201.e1. PubMed ID: 19969306
[TBL] [Abstract][Full Text] [Related]
40. Dose dependency of outcomes of intrapleural fibrinolytic therapy in new rabbit empyema models.
Komissarov AA; Florova G; Azghani AO; Buchanan A; Boren J; Allen T; Rahman NM; Koenig K; Chamiso M; Karandashova S; Henry J; Idell S
Am J Physiol Lung Cell Mol Physiol; 2016 Aug; 311(2):L389-99. PubMed ID: 27343192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
